Prof. Zoltán Kaló PhD András Borsi PhD(c)
Prof. Dr. Zoltan Kalo | Medicines for Europe
Sikereink
kalo@tatk.elte.hu 1
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary
ELTE Department of English Applied Linguistics | Budapest
PDF) Impact of multiple switching on health care costs and outcomes in generic drug policies: The Hungarian case of losartan
Health Care Challenges in Central & Eastern European Countries - YouTube
About us - Hungary - Selfie 2020 -
Sağlık Bilimleri Üniversitesi - Sağlık Ekonomisi Eğitimi Programı 2
Steps of economic evaluation Decision rule & sensitivity analysis - ppt download
MANAGING THE INTRODUCTION OF NEW AND HIGH-COST DRUGS IN CHALLENGING TIMES: THE EXPERIENCE OF HUNGARY AND POLAND
▻ Limited human resources and budget for HTA implementation ▻ At Western European prices medicines are usually not cost-effe
Health Policy, Planning and Financing MSc ELTE by ELTE TáTK - Issuu
ISPOR - Zoltán Kaló, PhD
Gaining an Appreciation of the Complexity of the Pharmaceutical R&D Process | Department of Public Policy
„A kulcs a tudatos tervezés”
Framework for HTA Implementation - ppt download
II. ELTE Biotechnológia FIEK szimpózium
Rektori kiválósági különdíj - galéria
PDF) Need for Multicriteria Evaluation of Generic Drug Policies
ELTE Reader
